Frailty Exacerbates Disability in Progressive Multiple Sclerosis
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks +10 more
wiley +1 more source
Proportion of medication error reporting and its associated factors among healthcare workers in Indonesia: A mixed-methods study. [PDF]
Pramesona BA +3 more
europepmc +1 more source
Prescriptions for Excellence in Health Care Spring 2010 Dowload Full PDF [PDF]
core +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Leveraging technology and human factor principles to improve outpatient medication reconciliation. [PDF]
Taha H +7 more
europepmc +1 more source
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
Identifying and Resolving Drug-Related Problems in Geriatric Patients. [PDF]
Peterson ME, Stollings JL, Ely EW.
europepmc +1 more source
[Medical education and the Brazilian hospital system].
openaire +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
The value of the AAGL staging system for predicting recurrence after conservative surgery for ovarian endometriomas. [PDF]
Qiu H, Lin W, Lin S, Shen M, Lin L.
europepmc +1 more source

